Login / Signup

Deregulated MicroRNAs involved in P53 Signaling Pathway in Breast Cancer with Focus on Triple-negative Breast Cancer.

Yasaman NaeimzadehZahra HeidariVahid RazbanSahar Khajehا
Published in: Current molecular pharmacology (2023)
Developing our knowledge about miRNA expression profile in BC, as well as molecular mechanisms of initiation and progression of BC can help to find new prognostic, diagnostic, and therapeutic biomarkers, which can lead to a suitable treatment for BC patients.
Keyphrases